Filing Flows › Geron (GERN) › Q2 2026 › vs Q2 2025
Geron (GERN) Q2 2026 vs Q2 2025 (year over year)
Geron's revenue rose $8.4M (+17%) from $49.0M in Q2 2025 to $57.5M in Q2 2026. The biggest changes: Product revenue, net +$8.5M (+17%); Royalties −$22K (-76%).
Geron, Q2 2026: revenue $57.5M (+17% year over year), operating margin -21.7%, net loss $16.7M, operating cash flow −$15.8M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $57.5M | $49.0M | $8.5M | +17% |
| Royalties | $7K | $29K | −$22K | -76% |
| Revenue | $57.5M | $49.0M | $8.4M | +17% |
| Net loss | $16.7M | $16.4M | $305K | +2% |
| Costs & expenses | $74.2M | $65.4M | $8.7M | +13% |
| Operating costs | $70.0M | $61.5M | $8.5M | +14% |
| Interest & other, net | $4.2M | $3.9M | $263K | +7% |
| Research & development | $22.0M | $21.7M | $294K | +1% |
| SG&A | $38.9M | $38.6M | $299K | +0.8% |
| Other operating costs | $9.1M | $1.2M | $7.9M | +663% |
| Operating cash sources | $20.9M | $34.3M | −$13.4M | -39% |
| Depreciation & amortization | $136K | $128K | $8K | +6% |
| Share-based compensation | $4.9M | $6.8M | −$1.8M | -27% |
| Cash used in operations | $15.8M | $27.4M | −$11.6M | -42% |
| Net loss absorbed | $16.7M | $16.4M | $305K | +2% |
| Working capital & other | $4.2M | $17.9M | −$13.7M | -76% |
Questions
How much did Geron's revenue grow year over year in Q2 2026?
Geron's revenue rose $8.4M (+17%) from $49.0M in Q2 2025 to $57.5M in Q2 2026.
What drove Geron's revenue change in Q2 2026?
Product revenue, net +$8.5M (+17%); Royalties −$22K (-76%).